These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 24224676)

  • 1. Regional brain glucose uptake distinguishes suicide attempters from non-attempters in major depression.
    Sublette ME; Milak MS; Galfalvy HC; Oquendo MA; Malone KM; Mann JJ
    Arch Suicide Res; 2013; 17(4):434-47. PubMed ID: 24224676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Positron emission tomography of regional brain metabolic responses to a serotonergic challenge and lethality of suicide attempts in major depression.
    Oquendo MA; Placidi GP; Malone KM; Campbell C; Keilp J; Brodsky B; Kegeles LS; Cooper TB; Parsey RV; van Heertum RL; Mann JJ
    Arch Gen Psychiatry; 2003 Jan; 60(1):14-22. PubMed ID: 12511168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Positron emission tomographic imaging of serotonin activation effects on prefrontal cortex in healthy volunteers.
    Mann JJ; Malone KM; Diehl DJ; Perel J; Nichols TE; Mintun MA
    J Cereb Blood Flow Metab; 1996 May; 16(3):418-26. PubMed ID: 8621746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regional brain responses to serotonin in major depressive disorder.
    Anderson AD; Oquendo MA; Parsey RV; Milak MS; Campbell C; Mann JJ
    J Affect Disord; 2004 Nov; 82(3):411-7. PubMed ID: 15555692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Positron emission tomography of regional brain metabolic responses to a serotonergic challenge in major depressive disorder with and without borderline personality disorder.
    Oquendo MA; Krunic A; Parsey RV; Milak M; Malone KM; Anderson A; van Heertum RL; John Mann J
    Neuropsychopharmacology; 2005 Jun; 30(6):1163-72. PubMed ID: 15770239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A fenfluramine-activated FDG-PET study of borderline personality disorder.
    Soloff PH; Meltzer CC; Greer PJ; Constantine D; Kelly TM
    Biol Psychiatry; 2000 Mar; 47(6):540-7. PubMed ID: 10715360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resting regional brain activity correlates of verbal learning deficit in major depressive disorder.
    Milak MS; Potter WA; Pantazatos SP; Keilp JG; Zanderigo F; Schain M; Sublette ME; Oquendo MA; Malone KM; Brandenburg H; Parsey RV; Mann JJ
    Psychiatry Res Neuroimaging; 2019 Jan; 283():96-103. PubMed ID: 30580237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pretreatment regional brain glucose uptake in the midbrain on PET may predict remission from a major depressive episode after three months of treatment.
    Milak MS; Parsey RV; Lee L; Oquendo MA; Olvet DM; Eipper F; Malone K; Mann JJ
    Psychiatry Res; 2009 Jul; 173(1):63-70. PubMed ID: 19446443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential brain metabolic predictors of response to paroxetine in obsessive-compulsive disorder versus major depression.
    Saxena S; Brody AL; Ho ML; Zohrabi N; Maidment KM; Baxter LR
    Am J Psychiatry; 2003 Mar; 160(3):522-32. PubMed ID: 12611834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased prefrontal, anterior cingulate, insula, and ventral striatal metabolism in medication-free depressed outpatients with bipolar disorder.
    Brooks JO; Wang PW; Bonner JC; Rosen AC; Hoblyn JC; Hill SJ; Ketter TA
    J Psychiatr Res; 2009 Jan; 43(3):181-8. PubMed ID: 18582900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regional cerebral glucose utilization in patients with a range of severities of unipolar depression.
    Kimbrell TA; Ketter TA; George MS; Little JT; Benson BE; Willis MW; Herscovitch P; Post RM
    Biol Psychiatry; 2002 Feb; 51(3):237-52. PubMed ID: 11839367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positron emission tomography quantification of serotonin(1A) receptor binding in suicide attempters with major depressive disorder.
    Sullivan GM; Oquendo MA; Milak M; Miller JM; Burke A; Ogden RT; Parsey RV; Mann JJ
    JAMA Psychiatry; 2015 Feb; 72(2):169-78. PubMed ID: 25549105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Positron emission tomography study of regional brain metabolic responses to a serotonergic challenge in major depressive disorder with and without comorbid lifetime alcohol dependence.
    Sher L; Milak MS; Parsey RV; Carballo JJ; Cooper TB; Malone KM; Oquendo MA; Mann JJ
    Eur Neuropsychopharmacol; 2007 Sep; 17(9):608-15. PubMed ID: 17478085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in regional brain glucose metabolism measured with positron emission tomography after paroxetine treatment of major depression.
    Kennedy SH; Evans KR; Krüger S; Mayberg HS; Meyer JH; McCann S; Arifuzzman AI; Houle S; Vaccarino FJ
    Am J Psychiatry; 2001 Jun; 158(6):899-905. PubMed ID: 11384897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopaminergic function in depressed patients with affective flattening or with impulsivity: [18F]fluoro-L-dopa positron emission tomography study with voxel-based analysis.
    Bragulat V; Paillère-Martinot ML; Artiges E; Frouin V; Poline JB; Martinot JL
    Psychiatry Res; 2007 Feb; 154(2):115-24. PubMed ID: 17306513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased brainstem and putamen SERT binding potential in depressed suicide attempters using [11C]-zient PET imaging.
    Nye JA; Purselle D; Plisson C; Voll RJ; Stehouwer JS; Votaw JR; Kilts CD; Goodman MM; Nemeroff CB
    Depress Anxiety; 2013 Oct; 30(10):902-7. PubMed ID: 23526784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Positron emission tomography quantification of serotonin transporter in suicide attempters with major depressive disorder.
    Miller JM; Hesselgrave N; Ogden RT; Sullivan GM; Oquendo MA; Mann JJ; Parsey RV
    Biol Psychiatry; 2013 Aug; 74(4):287-95. PubMed ID: 23453288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gray and white matter differences in adolescents and young adults with prior suicide attempts across bipolar and major depressive disorders.
    Fan S; Lippard ETC; Sankar A; Wallace A; Johnston JAY; Wang F; Pittman B; Spencer L; Oquendo MA; Blumberg HP
    J Affect Disord; 2019 Feb; 245():1089-1097. PubMed ID: 30699851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Positron emission tomography in female patients with borderline personality disorder.
    Juengling FD; Schmahl C; Hesslinger B; Ebert D; Bremner JD; Gostomzyk J; Bohus M; Lieb K
    J Psychiatr Res; 2003; 37(2):109-15. PubMed ID: 12842164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain monoamine oxidase A binding in major depressive disorder: relationship to selective serotonin reuptake inhibitor treatment, recovery, and recurrence.
    Meyer JH; Wilson AA; Sagrati S; Miler L; Rusjan P; Bloomfield PM; Clark M; Sacher J; Voineskos AN; Houle S
    Arch Gen Psychiatry; 2009 Dec; 66(12):1304-12. PubMed ID: 19996035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.